Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients PORTICO plans to recruit 188 ...
Teva announced the launch of Eptifibatide Injection, the generic version of Merck's Integrilin. Integrilin is a GP IIb/IIIa blocker antiplatelet indicated for acute coronary syndrome, including ...
MADRID, Spain and BOSTON, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results